Showing results (171-180 of 21,754) with videos related to
Sort By:
Pageof 2,176
British Journal of Cancer|January 15, 2009
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in JapanM Kondo, S-L Hoshi, M ToiBritish Journal of Cancer|January 15, 2009
Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?G Grazzini, C B Visioli, M Zorzi, et al.British Journal of Cancer|January 15, 2009
Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progressionM Anders, M Vieth, C Röcken, et al.British Journal of Cancer|June 1, 1991
A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working PartyR L Hayward, R C Leonard, R J PrescottBritish Journal of Cancer|June 1, 1991
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles CountyH Shimizu, R K Ross, L Bernstein, et al.British Journal of Cancer|July 22, 2010
Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patientsM Russo, C Spagnuolo, S Volpe, et al.British Journal of Cancer|July 22, 2010
Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer ScreeningL Fallowfield, A Fleissig, J Barrett, et al.British Journal of Cancer|October 28, 2010
Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantationS Ash, J Stein, N Askenasy, et al.British Journal of Cancer|October 28, 2010
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cellsY Tomimaru, H Eguchi, H Nagano, et al.British Journal of Cancer|October 28, 2010
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancerS Guiu, M Gauthier, B Coudert, et al.Pageof 2,176